← Back to all trials
Not Yet Recruiting
NCT05628077
Prevalence and Risk Factors for Sleep and Pain Among Breast Cancer Survivors on Aromatase Inhibitors
Conditions: Breast Cancer, Aromatase Inhibitors, Endocrine Therapy, Pain, Anxiety, Depression, Sleep
Sex: Female
Ages: 18 Years – 90 Years
Enrollment: 1200
Sponsor: Peking University People's Hospital
Summary
We obtained the occurrence of pain sensation, pain mood, sleep, etc. during endocrine therapy in breast cancer patients through telephone follow-up, and analyzed risk factors through artificial intelligence
Eligibility Criteria
Inclusion Criteria:- Breast cancer survivors on aromatase inhibitorsExclusion Criteria:Advanced breast cancer
Source: ClinicalTrials.gov (NCT05628077). StuddyBuddy aggregates publicly available trial information.
